Bertin Bioreagent

anti-CRABP II (Cellular retinoic acid binding protein II), mAb (4C9)

As low as CHF 777.00
In stock
Only %1 left
BRT-G01004-R100100 µlCHF 777.00
NEW
 
More Information
Product Details
Synonyms Cellular Retinoic Acid-binding Protein 2
Product Type Monoclonal Antibody
Properties
Clone 4C9
Isotype Mouse IgG1κ
Source/Host Mouse
Immunogen/Antigen Synthetic peptide.
Application ELISA, Western Blot, Immunocytochemistry. Recommended dilution: 1/500- 1/5000
Specificity Recognizes mouse CRABPII. No cross reactivity on human CRABPII and on CRABPI.
Formulation Liquid. Does not contain any preservative.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Bertin Bioreagent
Shipping and Handling
Shipping BLUE ICE
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
Product Specification Sheet
Datasheet Download PDF
Description
The vitamin A metabolite retinoic acid (RA) regulates gene transcription by activating several members of the nuclear receptor family of ligand-activated transcription factors: the classical RA receptors RARα, RARβ, and RARγ and the peroxisome proliferator-activated receptor β/δ (PPARβ/δ). The partitioning of the hormone between its receptors is regulated by two intracellular lipid-binding proteins, cellular retinoic acid-binding protein type II (CRABP-II), which delivers RA to RAR, and fatty acid-binding protein type 5 (FABP5), which shuttles it to PPARβ/δ.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.